Lilly Korea launches ActosMet

Published: 2008-07-24 06:49:00
Updated: 2008-07-24 06:49:00
Lilly Korea says it has launched its ActosMet (Actos 15 mg + metformin 850 mg) tablets for treatment of 2 diabetes - namely insulin resistance.

Actos is a clinically proven, once a day medicine that belongs to a class of oral Type 2 diabetes drugs called thiazoildinediones. Additionally, Actos...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.